Home > PE Ratio > ASPIRA PATHLAB & DIAGNOSTICS

ASPIRA PATHLAB & DIAGNOSTICS
PE (Price/Earnings) Ratio

The Current P/E Ratio of ASPIRA PATHLAB & DIAGNOSTICS is 49.12.

Share Price ₹122.0Jun 19,2026
Market Cap ₹125.7 Cr
Earnings-TTM₹2.6 CrTTM-Consolidated Results
Price/Earnings49.12xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for ASPIRA PATHLAB & DIAGNOSTICS
Please provide your vote to see the results
ASPIRA PATHLAB & DIAGNOSTICS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of ASPIRA PATHLAB & DIAGNOSTICS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of ASPIRA PATHLAB & DIAGNOSTICS is calculated as :

Current Market Cap [ ₹125.7 Cr] as on Jun 19,2026

(/) Earnings [ ₹2.6 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 49.12x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for ASPIRA PATHLAB & DIAGNOSTICS , the investors are currently willing to pay 49.12 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ASPIRA PATHLAB & DIAGNOSTICS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of ASPIRA PATHLAB & DIAGNOSTICS over the last five years.

Historical PE (Price/Earnings) ratio chart of ASPIRA PATHLAB & DIAGNOSTICS


PE Ratio Performance Analysis for ASPIRA PATHLAB & DIAGNOSTICS

- ASPIRA PATHLAB & DIAGNOSTICS 's latest p/e ratio is 49.12x.

- ASPIRA PATHLAB & DIAGNOSTICS 's p/e ratio for fiscal years ending Mar2025 to Mar2024 averaged 21.69x.

- ASPIRA PATHLAB & DIAGNOSTICS 's operated at median p/e ratio of 43.37x from fiscal years ending March 2018 to 2022.

- Looking back at the last 2 fiscal years, ASPIRA PATHLAB & DIAGNOSTICS 's p/e ratio peaked in Mar2025 at 43.37x.

- ASPIRA PATHLAB & DIAGNOSTICS 's p/e ratio hit its five-year low in Mar2024 of 0x.


How does ASPIRA PATHLAB & DIAGNOSTICS 's P/E Ratio benchmark against top 10 peers in Hospital & Healthcare Services Industry?

Peer Comparison (Hospital & Healthcare Services Industry)Earnings-TTM (Cr)PE RatioMarket Cap
ASPIRA PATHLAB & DIAGNOSTICS 2.5649.12125.7
APOLLO HOSPITALS ENTERPRISE LTD1,957.7062.41122,171.0
MAX HEALTHCARE INSTITUTE LTD1,442.4173.95106,672.0
FORTIS HEALTHCARE LTD1,047.8469.3872,698.7
ASTER DM HEALTHCARE LTD464.1090.3241,916.0
NARAYANA HRUDAYALAYA LTD816.0447.0238,373.9
GLOBAL HEALTH LTD554.0761.3533,992.9
KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD239.40134.4932,197.2
DR LAL PATHLABS LTD509.8053.8027,424.7
DR AGARWALS HEALTH CARE LTD168.1488.1814,826.9
RAINBOW CHILDRENS MEDICARE LTD281.5453.2815,000.3

Hospital & Healthcare Services Industry Benchmark (Top 10) PE Analysis vs ASPIRA PATHLAB & DIAGNOSTICS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 47.02x
Max industry PE 134.49x
Median industry PE 62.41x
Average industry PE 71.21x



You may also like the below Video Courses